SSX Antibody

• Description:

  The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. This gene, and also the SSX2 and SSX4 family members, have been involved in t (X;18) (p11. 2; q11. 2) translocations that are characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are likely responsible for transforming activity. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome X.

• Immunogen:

  The antiserum was produced against synthesized peptide derived from the C-terminal region of human SSX1/2/3/4/5/6/7/8/9. AA range:139-188

• Antibody Type:

  Primary Antibodies

• Product Name Synonym:

  SSX1 antibody; Protein SSX1 antibody; Cancer/testis antigen 5.1 antibody; CT5.1 antibody; Synovial sarcoma, X breakpoint 1 antibody; SSX2 antibody; SSX2A antibody; SSX2B antibody; Protein SSX2 antibody; Cancer/testis antigen 5.2 antibody; CT5.2 antibody; Synovial sarcoma, X breakpoint 2 antibody; Tumor antigen HOM-MEL-40 antibody; SSX3 antibody; Protein SSX3 antibody; Cancer/testis antigen 5.3 antibody; CT5.3 antibody; SSX4 antibody; SSX4A antibody; SSX4B antibody; Protein SSX4 antibody; Cancer/testis antigen 5.4 antibody; CT5.4 antibody; SSX5 antibody; Protein SSX5 antibody; SSX6 antibody; Putative protein SSX6 antibody; SSX7 antibody; Protein SSX7 antibody; SSX8 antibody; Protein SSX8 antibody; SSX9 antibody; Protein SSX9 antibody